Tokyo, Japan · Founded 2017 · Privately Held (backing)
Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. Aillis is based in Tokyo, Japan and was founded in 2017. Its last reported valuation was $125 million in Apr 2025. It has raised $54.6 million.
Last reported valuation
$125.2M
Oct 2026
Priced at
—
Total raised
$54.6M
Last round
—
Team — not yet on record
No current team members for Aillis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aillis with a free account
·The complete investor list: 27 names
·Watch Aillis: the Monday email on marks, rounds and moves
